News and Press Releases
RegSmart appoints new CEO as part of planned leadership transition
RegSmart has appointed Åsa Magnusson as new Chief Executive Officer, effective 7 April 2026. The appointment is part of a planned leadership transition and supports the company’s continued development and long-term positioning within regulatory...
Iris Rajman new board member of CTR
Iris Rajman MD, PhD has been apponted as a new board member of Center for Translational Research (CTR). Iris is a pharmaceutical industry executive with extensive senior leadership experience across global pharma companies. She brings deep...
Triple leadership changes within CTR will position the corporate group for its next phase of growth
Today, Center for Translational Research AB (CTR) announced three major internal leadership changes within the corporate group, with new CEOs for CTC Clinical Trial Consultants AB (CTC) and Toxicology Knowledge Team Sweden AB (TKT), and a new role...
RegSmart Life Science and RegFile merge
RegSmart Life Science AB and RegFile AB announces today that they are merging to offer an even more comprehensive support to companies in pharmaceutical development and medical device. The combined entity will operate under the name RegSmart, with...
Center for Translational Research acquires Zelmic AB
Center for Translational Research AB (CTR) expands by acquiring Zelmic AB, the GMP-approved Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), specialized in development of topical and transdermal...
Grand opening of CTC Netherlands early phase clinical unit on June 19
CTC Netherlands BV is excited to announce the official opening of a state-of-the-art early phase clinical unit with 12 beds on the premises of the University Medical Center Groningen (UMCG) on June 19, 2024. “The clinic focuses on high-end early...
Center for Translational Research launches CTC Netherlands
29 February, 2024 Center for Translational Research expands its portfolio of life science service companies through the establishment of CTC Netherlands BV – the CTR group’s first company outside of Sweden. Sweden-based Center for Translational...
CTR Center for Translational Research AB acquires A+ Science AB
CTR Center for Translational Research AB (CTR) has recently completed a strategic acquisition of A+ Science AB. As part of the agreement, all operations within A+ will be integrated into CTR's wholly-owned subsidiary, CTC Clinical Trial Consultants...
CTR establishes QAlliance – Quality assurance in Life Science
CTR starts a new subsidiary - QAlliance AB - to support the Life Science industry with expertise and operational support within QA, quality assurance. The business will be led by Raf Lemmens, who has been appointed CEO of the company. In recent...